BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17592507)

  • 1. Propranolol causes a paradoxical enhancement of cardiomyocyte foetal gene response to hypertrophic stimuli.
    Patrizio M; Musumeci M; Stati T; Fasanaro P; Palazzesi S; Catalano L; Marano G
    Br J Pharmacol; 2007 Sep; 152(2):216-22. PubMed ID: 17592507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Propranolol promotes Egr1 gene expression in cardiomyocytes via beta-adrenoceptors.
    Patrizio M; Musumeci M; Stati T; Fecchi K; Mattei E; Catalano L; Marano G
    Eur J Pharmacol; 2008 Jun; 587(1-3):85-9. PubMed ID: 18485346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol enhances cell cycle-related gene expression in pressure overloaded hearts.
    Musumeci M; Maccari S; Sestili P; Signore M; Molinari P; Ambrosio C; Stati T; Colledge WH; Grace AA; Catalano L; Marano G
    Br J Pharmacol; 2011 Dec; 164(8):1917-28. PubMed ID: 21615725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of aortic banding-induced cardiac hypertrophy by propranolol is independent of beta-adrenoceptor blockade.
    Marano G; Palazzesi S; Fadda A; Vergari A; Ferrari AU
    J Hypertens; 2002 Apr; 20(4):763-9. PubMed ID: 11910314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of endogenous ouabain-like compound in the cardiac hypertrophic process in vivo.
    Skoumal R; Szokodi I; Aro J; Földes G; Göoz M; Seres L; Sármán B; Lakó-Futó Z; Papp L; Vuolteenaho O; Leppäluoto J; DeChâtel R; Ruskoaho H; Tóth M
    Life Sci; 2007 Mar; 80(14):1303-10. PubMed ID: 17266992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signaling pathway-focused gene expression profiling in pressure overloaded hearts.
    Musumeci M; Maccari S; Corritore E; Massimi A; Stati T; Marano G; Catalano L
    Ann Ist Super Sanita; 2011; 47(3):290-5. PubMed ID: 21952155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac steroidogenesis and glucocorticoid in the development of cardiac hypertrophy during the progression to heart failure.
    Ohtani T; Mano T; Hikoso S; Sakata Y; Nishio M; Takeda Y; Otsu K; Miwa T; Masuyama T; Hori M; Yamamoto K
    J Hypertens; 2009 May; 27(5):1074-83. PubMed ID: 19349910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin Attenuates Angiotensin II-induced Cardiomyocyte Hypertrophy by Inhibiting the Ca(2+)/Calcineurin-NFAT Signaling Pathway.
    Yin Z; Wang X; Zhang L; Zhou H; Wei L; Dong X
    Cardiovasc Ther; 2016 Feb; 34(1):21-9. PubMed ID: 26506219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Norepinephrine upregulates vascular endothelial growth factor in rat cardiac myocytes by a paracrine mechanism.
    Weil J; Benndorf R; Fredersdorf S; Griese DP; Eschenhagen T
    Angiogenesis; 2003; 6(4):303-9. PubMed ID: 15166499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressure-independent cardiac hypertrophy in mice with cardiomyocyte-restricted inactivation of the atrial natriuretic peptide receptor guanylyl cyclase-A.
    Holtwick R; van Eickels M; Skryabin BV; Baba HA; Bubikat A; Begrow F; Schneider MD; Garbers DL; Kuhn M
    J Clin Invest; 2003 May; 111(9):1399-407. PubMed ID: 12727932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-Dependent Kinase Inhibitor p21WAF1/CIP1 Facilitates the Development of Cardiac Hypertrophy.
    Tong YF; Wang Y; Ding YY; Li JM; Pan XC; Lu XL; Chen XH; Liu Y; Zhang HG
    Cell Physiol Biochem; 2017; 42(4):1645-1656. PubMed ID: 28746924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
    Nelson TJ; Balza R; Xiao Q; Misra RP
    J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway.
    Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R
    Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal regulation of β-myosin heavy chain expression in the mouse left ventricle.
    Patrizio M; Musumeci M; Piccone A; Raggi C; Mattei E; Marano G
    J Endocrinol; 2013 Mar; 216(3):287-96. PubMed ID: 23179080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of adenosine A1 receptor attenuates cardiac hypertrophy and prevents heart failure in murine left ventricular pressure-overload model.
    Liao Y; Takashima S; Asano Y; Asakura M; Ogai A; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Ogita H; Tomoike H; Hori M; Kitakaze M
    Circ Res; 2003 Oct; 93(8):759-66. PubMed ID: 12970111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
    Ebihara Y; Karmazyn M
    Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.